Abstract
Despite major advances in research into and treatment of cancer, there remain exceptional difficulties arising from the disease’s complexity and variability. These could be eased by integrated systems approaches to biology, bioinformatics and medicine. Such approaches have already proved successful in optimizing cancer-related research and clinical applications, building upon existing practice. In particular, they enhance the quantitative basis of knowledge and decisions; organize information in more accessible and applicable ways; extend understanding of complicated biological interactions; and provide numerical test beds for planning and implementing biomarker and drug development and treatment strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abeloff et al (2008) Abeloff’s clinical oncology, 4th edn. Elsevier, Churchill Livingston, London
Aebersold R, Auffray C, Baney E, Barillot E, Brazma A, Brett C, Brunak S, Butte A, Califano A, Celis J, Cufer T, Ferrell J, Galas D, Gallahan D, Gatenby R, Goldbeter A, Hace N, Henney A, Hood L, Iyengar R, Jackson V, Kallioniemi O, Klingmuller U, Kolar P, Kolch W, Kyriakopoulou C, Laplace F, Lehrach H, Marcus F, Matrisian L, Nolan G, Pelkmans L, Potti A, Sander C, Seljak M, Singer D, Sorger P, Stunnenberg H, Superti-Furga G, Uhlen M, Vidal M, Weinstein J, Wigle D, Williams M, Wolkenhauer O, Zhivotovsky B, Zinovyev A, Zupan B (2009) Report on EU-USA workshop: how systems biology can advance cancer research (27 Oct 2008). Mol Oncol 3(1):9–17
Aherne GW, McDonald E, Workman P (2002) Finding the needle in the haystack: why high-throughput screening is good for your health. Breast Cancer Res 4:148–154
Anderson JC, Clarke EJ, Arkin AP, Voigt CA (2006) Environmentally controlled invasion of cancer cells by engineered bacteria. J Mol Biol 355(4):619–627
Anderson JC, Voigt CA, Arkin AP (2007) Environmental signal integration by a modular AND gate. Mol Syst Biol 3:133
ANGIOTARGETING (2010) Tumour angiogenesis research. http://www.uib.no/rg/trancancer/projects/angiotargeting. Accessed 18 Oct 2010
APO-SYS (2010) Apoptosis systems biology applied to cancer and AIDS. http://www.apo-sys.eu/. Accessed 18 Oct 2010
Arnesen T et al (2008) The protein acetyltransferase ARD1: a novel cancer drug target? Curr Cancer Drug Targets 8(7):545–553
Asset (2011) Analysis and striking the sensitivities of embryonal tumours. http://www.ucd.ie/sbi/research/areasofresearch/sbicollaborativeprojects/asset/. Accessed 30 Jan 2011
ATTACK (2010) Adoptive engineered T cell targeting to activate cancer killing. http://www.attack-cancer.org. Accessed 18 Oct 2010
Auffray C, Chen Z, Hood L (2009) Systems medicine: the future of medical genomics and healthcare. Genome Med 2009, 1:2. doi:10.1186/gm2
Beckman RA, Loeb LA (2005) Review—genetic instability in cancer: theory and experiment. Semin Cancer Biol 15:423–435
BioSapiens (2010) A European virtual institute for genome annotation. http://www.biosapiens.info. Accessed 18 Oct 2010. See also BioSapiens (2005) A European network for integrated genome annotation. Eur J Hum Genet 13:994–997
BioSapiens-WP 109 (2010) BioSapiens work package 109—cancer. http://www.biosapiens.info/page.php?page=package&pack=109&new=1. Accessed 18 Oct 2010
BioSim (2010) Biosiumulation—a new tool in drug development. http://biosim-network.eu/. Accessed 18 Oct 2010
BRECOSM (2010) Identification of molecular pathways that regulate the organ-specific metastasis of breast cancer. http://www.healthcompetence.eu/converis/publicweb/project/1693;jsessionid=397ae485b508dd6ec6d1b1106f19?show=Person. Accessed 18 Oct 2010
Byrne HM, Leeuwen IMM van, Owen MR, Alarcon T, Maini PK (2008) Multiscale modelling of solid tumour growth. In: Selected topics in cancer modeling. Genesis, evolution, immune competition, & therapy. Birkhauser, Boston, pp 449–473. ISBN 978-0-8176-4712-4
caBIG (2010) Cancer biomedical information grid (caBIG™) of the NCI (2010) https://cabig.nci.nih.gov/. Accessed 18 Oct 2010
Cancer Facts (2010) Cancer facts and figures 2009. http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2009_Presentation.asp. Accessed 18 Oct 2010
Cancer Genome Project (2010) The WTSI (2010) Cancer genome project. http://www.sanger.ac.uk/genetics/CGP/. Accessed 18 Oct 2010
Cancer Research UK (2006) “Virtual cancer patient” predicts how breast cancer patients respond to treatment. http://info.cancerresearchuk.org/news/archive/pressrelease/2006-10-10-virtual-cancer-patient-predicts-how-breast-cancer-patients-respond-to-treatment
Cancersys (2010) Cancersys project. http://www.ifado.de/cancersys/. Accessed 18 Oct 2010
Carden C et al (2009) From darkness to light with biomarkers in early clinical trials of cancer drugs. Clin Pharmacol Ther 85(2):131–133. Issn 0009-9236
Cassidy J, Bissett D, Spence RAJ (2002) Oxford handbook of oncology. Oxford University Press, Oxford
Cassman M, Brunak S (2007) The US-EC workshop on infrastructure needs for systems biology. http://ec.europa.eu/research/biotechnology/ec-us/index_en.html. Accessed 18 Oct 2010
Cellis J (2008) Editorial. Mol Oncol 2(1):1
Cell lines (2010) Cell lines from high-risk breast tissue. http://clinicaltrials.gov/ct2/show/NCT00032201. Accessed 18 Oct 2010
Cesario et al (2004) Non-small cell lung cancer: from cytotoxic systemic chemotherapy to molecularly targeted therapy. Curr Med Chem Anticancer Agents 4(3):231–245
Chan JK (2001) The new world health organization classification of lymphomas: the past, the present and the future. Hematol Oncol 19:129–150
Chassagnole C et al (2006) Using mammalian cell cycle simulation to interpret differential kinase inhibition in anti-tumour pharmaceutical development. Biosystems 83(2–3):91–97
CNIO Training (2010) Spanish national cancer institute. http://www.cnio.es/ing/cursos/. Accessed 18 Oct 2010
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073–1081. Epub 2009 May 25
COMBIO (2010) An integrative approach to cellular signalling and control processes: bringing computational biology to the bench. http://combio.crg.es. Accessed 18 Oct 2010
CORDIS (2010) Community Research and Development Information Service (CORDIS) provides information on all EU-supported R&D activities. http://cordis.europa.eu/home_en.html. Accessed 18 Oct 2010
CORDIS Projects (2010) Cordis project reference systems. http://cordis.europa.eu/fp7/projects_en.html. Accessed 18 Oct 2010
COSBICS (2010) Computational systems biology of cell signalling. http://www.sbi.informatik.uni-rostock.de/cosbics/. Accessed 18 Oct 2010
CVIT (2010) The center for the development of a virtual tumour. https://www.cvit.org. Accessed 18 Oct 2010
Daskalaki A (2009) Handbook of research on systems biology applications in medicine. ISBN: 978-1-60566-076-9. doi: 10.4018/978-1-60566-076-9. IGI Global, Pennsylvania, pp 1–982
De Duve (2009) De Duve Institute. http://www.deduveinstitute.be/cancer_immunology.php
Deisboeck TS, Stamatakos G (2010) Multiscale cancer modelling. CRC press. ISBN 9781439814406.
Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAPK kinase signalling pathways in cancer. Oncogene 26(22):3279–3290
DIAMONDS (2010) Dedicated integration and modelling of novel data and prior knowledge to enable systems biology. http://www.sbcellcycle.org. Accessed 18 Oct 2010
DNA Repair (2010) DNA damage response and repair mechanisms. http://www.dna-repair.nl. Accessed 18 Oct 2010
Druker BJ (2002) ST1571 (Gleevec) as a paradigm for cancer therapy. Trends Mol Med 8(Suppl):S14–S18
DTU-CBS Databases (2010) Danish technical university, centre for biological sequence analysis. http://www.cbs.dtu.dk/databases/. Accessed 18 Oct 2010
EBI (2010) European bioinformatics institute. http://www.ebi.ac.uk/. Accessed 18 Oct 2010
EMBRACE (2010) A European model for bioinformatics research and community education—bioinformatics grid. http://www.embracegrid.info. Accessed 18 Oct 2010
ENFIN (2010) Enabling systems biology PP6 (2007) project. http://www.enfin.org. Accessed 18 Oct 2010
ESBIC-D (2010) European systems biology initiative combating complex diseases. http://www.healthcompetence.eu/converis/publicweb/project/2128/. Accessed 18 Oct 2010
Eriguchi M, Levi F, Hisa T,Yanagie H, Nonaka Y, Takeda Y (2003) Chronotherapy for cancer. Biomed Pharmacother 57:92s–95s
Faratian D et al (2009). Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res 69(16):6713–6720. http://www.csa.com. Accessed 18 Oct 2010
FCSB (2008) FCSB 2008 first future challenge for systems biology. http://systems-biology.org/conference/report/2008-calendar-1/000005.html
Fisher PB (2007) Cancer genomics and proteomics: methods and protocols. Humana Press, New York
FP7 (2010) EC framework programme for research. http://cordis.europa.eu/fp7/home_en.html. Accessed 18 Oct 2010
Fulda S (2009) Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med Jul;13(7):1221–1227. Epub 2009 Mar 27
Gatenby R (2009) A change of strategy in the war on cancer. Nature 459:508–509
GEN2PHEN (2010) Genotype to phenotype databases. http://www.gen2phen.org. Accessed 18 Oct 2010
Godoy P et al (2009) Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis. Hepatology 49(6):2031–2043
Gogvadze V, Orrenius S, Zhivotovsky B (2009) Mitochondria as targets for chemotherapy. Apoptosis 14(4):624–640
Hache H et al (2009) GeNGe: systematic generation of gene regulatory networks. Bioinformatics 25(9):1205–1207
Hahn WC, Weinberg RA (2002) Modelling the molecular circuity of cancer. Nat Rev Cancer 2(5):331–341
Hainaut P, Wiman KG (eds) (2007) 25 years of p53 research. Springer, Dordrecht
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Harris AL (2005) Editorial—REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:385–386. doi:10.1038/sj.bjc.6602730 http://www.bjcancer.com. Published online. Accessed 16 Aug 2005
Heath JR, Davis ME, Hood L (2009) Nanomedicine targets cancer. Sci Am 300(2):44–51
Hengstler JG et al (2006) Oncogene-blocking therapies: new insights from conditional mouse tumour models. Curr Cancer Drug Targets 6(7):603–612
HepatoSys (2010) German network systems biology hepatocyte programme. http://www.systembiologie.de/de/index.html. Accessed 18 Oct 2010
Hoffmann J et al (2008) Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Res 68(13):5301–5308
Hornberg JJ et al (2006) Cancer: a systems biology disease. Biosystems 83(2–3):81–90. http://www.csa.com. Accessed 18 Oct 2010
ICBP (2010) Integrative cancer biology programme of the NCI (2010) http://icbp.nci.nih.gov/. Accessed 18 Oct 2010
ICGC (2010) International cancer genome consortium. http://www.icgc.org. Accessed 18 Oct 2010
ICSB (2010) International conferences on systems biology. http://www.icsb2010.org.uk/. Accessed 18 Oct 2010
IMGT® (2010) The international ImMunoGeneTics information system. http://www.imgt.org. Accessed 18 Oct 2010
IMMUNOGRID (2010) The European virtual human immune system project. http://www.immunomics.eu/index.php?option=com_content&view=article&id=5%3Aimmunogrid-project-brief-description&catid=2%3Aimmunogrid&Itemid=10&lang=en. Accessed 18 Oct 2010
Jain KK (2009) Textbook of personalized medicine. Springer, New York
Jemal A (2009) Cancer statistics. CA Cancer J Clin 59:225–249. doi:10.3322/caac.20006
Johnson CJ, Zhukovsky N, Cass AE, Nagy JM (2008) Proteomics, nanotechnology and molecular diagnostics. Proteomics 8:715–730
Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ (2007) Mathematical modelling of cell population dynamics in the colonic crypt and in colorectal cancer. PNAS 104(10):4008–4013. See also http://www.pnas.org/cgi/reprint/104/10/4008.pdf. Accessed 18 Oct 2010
Khalil IG, Hill C (2005) Systems biology for cancer. Curr Opin Oncol 17(1):44–48. http://www.csa.com. Accessed 18 Oct 2010
Kim D, Rath O, Kolch W, Cho KH (2007) A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways. Oncogene 26(31):4571–4579
Kitano H (2004) Opinion: cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4:227–235. doi:10.1038/nrc1300
Klingmüller U et al (2006) Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modeling of signal transduction pathways. IEE Proc Syst Biol Nov;153(6):433–447.
Klipp E, Liebermeister W, Herwig, WC, Kowald A, Lehrach H, Herwig R (2009) Systems biology—a textbook. Wiley-VCH, Weinheim
Knox SS (2010) From ‘omics’ to complex disease: a systems biology approach to gene-environment interactions in cancer. Cancer Cell Int 10:11–11. http://www.csa.com. Accessed 18 Oct 2010
Kreeger PK, Lauffenburger DA (2010) Cancer systems biology: a network modeling perspective. Carcinogenesis Jan;31(1):2–8. Epub 2009 Oct 27
Kriegsheim A, Preisinger C, Kolch W (2008) Mapping of signalling pathways by functional interaction proteomics. Methods Mol Biol 484:177–192
Krebs HA (1953) 1953 nobel prize in medicine or physiology. http://nobelprize.org/nobel_prizes/medicine/laureates/1953/index.html. Accessed 18 Oct 2010
Kyriakopoulou C (ed) (2009) The book of life. Published European commission. ftp://ftp.cordis.europa.eu/pub/fp7/docs/fungen-book_en.pdf
Kyriakopoulou C (ed) (2010) Workshop on from systems biology to systems medicine. European Commission, Brussels. http://ec.europa.eu/research/health/pdf/systems-medicine-booklet_en.pdf. Accessed 18 Oct 2010
Lehrach H et al (1990) Hybridization fingerprinting in genome mapping and sequencing. Genome analysis, vol 1: genetic and physical mapping. Cold Spring Harbor Laboratory Press, New York, pp 39–81
Liu ET (2003) Classification of cancers by expression profiling. Curr Opin Genet Dev 13(1):97–103
Lymphangiogenomics (2010) Genome-wide discovery and functional analysis of novel genes in lymphangiogenesis. http://www.lymphomic.org/. Accessed 18 Oct 2010
Maini PK, Gatenby RA (2006) Some mathematical modelling challenges and approaches in cancer. In: Nagl S (ed) Cancer bioinformatics: from therapy design to treatment. Wiley, New York, pp 95–107
Makarow M et al (2008) Advancing systems biology for medical applications. http://www.esf.org. Accessed 18 Oct 2010
Mani K (2010) Systems biology and personalized medicine in cancer. Curr Pharmacogenomics Personalized Med (Formerly Current Pharmacog) 8(1):64–72(9)
Marcus FB (2008) Bioinformatics and systems biology: collaborative research and resources. Springer, Berlin
Materi W, Wishart DS (2007) Computational systems biology in cancer: modeling methods and applications. Gene Regul Syst Biol Sep 17;1:91–110
McShane LM et al (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:387–391
Mills GB (2009) M.D. Anderson cancer center. http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/systems-biology/chair-message.html. Accessed 18 Oct 2010
Mismatch2model (2010) Characterization and quantitative modelling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance. http://www.mm2m.eu/index.html. Accessed 18 Oct 2010
MIT-CSB (2010) Computational and systems biology at MIT. http://csbi.mit.edu/education/core.html. Accessed 18 Oct 2010
MIT-Koch (2011) Koch institute for integrative cancer research. MIT. http://web.mit.edu/ki/. Accessed 5 Jan 2011
MIT-opencourseware (2011) MIT open courseware. http://ocw.mit.edu. Accessed 4 Jan 2011
Modhep (2011) Systems biology of liver cancer: an integrative genomic-epigenomic approach. http://cordis.europa.eu/fetch?CALLER=PROJ_EN&ACTION=D&DOC=16&CAT=PROJ&QUERY=01238acac6d1:af70:07e5f5e3&RCN=97663. Accessed 30 Jan 2011
Mukherjee A et al (2005) Virtual cancer patient: simulated biomathematical model for treatment personalisation in metastatic breast cancer (MBC). http://www.optimata.com/src/VIRTUAL%20CANCER%20PATIENT(1).pdf
Mutp53 (2010) Mutant p53 as a target for cancer treatment. http://www.mutp53.com/executive_summary. Accessed 18 Oct 2010
Nagl S (ed) (2006) Cancer bioinformatics: from therapy design to treatment. Wiley, Chichester
NCI (2010) National cancer institute of the national institutes of health. http://www.cancer.gov/. Accessed 18 Oct 2010
NCI60 (2010) Discovery services. http://dtp.nci.nih.gov/docs/misc/common_files/cell_list.html. Accessed 18 Oct 2010
NHGRI (2010) National human genome research institute of the NIH. http://www.genome.gov/. Accessed 18 Oct 2010
OCISB (2010) Oxford centre for integrative systems biology. http://www.sysbio.ox.ac.uk/. Accessed 18 Oct 2010
Optimata (2010) http://www.optimata.com. Accessed 18 Oct 2010
Owen MR, Alarcon T, Maini PK, Byrne HM (2009) Angiogenesis and vascular remodelling in normal and cancerous tissues. J Math Biol 58(4–5):689–721
Oxford-SB (2010) Oxford systems biology doctoral training centre. http://www.sysbiodtc.ox.ac.uk/. Accessed 18 Oct 2010
Paik S et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817–2826
Parkinson H, Brazma A et al (2009) ArrayExpress update—from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37(Database issue):D868–D872. Epub 2008 Nov 10
PDQ (2010) PDQ-NCI’s comprehensive cancer database. http://www.cancer.gov/cancertopics/pdq/cancerdatabase. Accessed 18 Oct 2010
Physiomics (2010) Physiomics plc, 2010. http://www.physiomics-plc.com. Accessed 18 Oct 2010
Physiomics Virtual Tumour (2010) Physiomics virtual tumour. http://www.physiomics-plc.com/results-update-%E2%80%93-virtual-tumour/. Accessed 18 Oct 2010
Price ND, Foltz G, Madan A, Hood L, Tian Q (2008) Systems biology and cancer stem cells. J Cell Mol Med 12(1):97–110. http://www.csa.com. Accessed 18 Oct 2010
Ptitsyn AA, Wei MM, Thamm DH (2008). Systems biology approach to identification of biomarkers for metastatic progression in cancer. BMC Bioinform [computer file] 9(Suppl 9):S8. http://www.csa.com. Accessed 18 Oct 2010
Reactome (2010) Reactome—a curated knowledgebase of biological pathways. http://reactome.org/. Accessed 18 Oct 2010
Rosenfeld S, Kapetanovic I (2008) Systems biology and cancer prevention: all options on the table. Gene Regul Syst Biol Oct 10;2:307–319.
Rowe A (2009) Experimental drug makes the immune system revolt against cancer. http://www.wired.com/wiredscience/tag/synthetic-biology
Sanga S, Sinak J, Frieboes B, Ferrari M, Freuhauf J, Cristini V (2006) Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev. Anticancer Ther 6(10):1361–1376
Sanger Genetics (2010) Genomics and genetics at the sanger institute. http://www.sanger.ac.uk/research/areas/humangenetics/. Accessed 18 Oct 2010
Seigneuric R, Riel NAW van, Starmans MHW, Erk A van (2009) Systems biology applied to cancer research. pp 339–353 in Daskalaki (2009)
Sen F, Vega F, Medeiros LJ (2002) Molecular genetic methods in the diagnosis of hematologic neoplasms. Semin Diagn Pathol 19:72–93
Singer S (1999) New diagnostic modalities in soft tissue sarcoma. Semin Surg Oncol 17:11–22.
Sybilla (2009) Systems biology of T-cell activation in health and disease. http://www.sybilla-t-cell.de/
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785):177–182
Sysbiomed-cancer (2010) Sysbiomed workshop on systems biology and cancer. http://www.healthcompetence.eu/converis/publicweb/project/1123. Accessed 18 Oct 2010
Syscol (2011) Systems biology of colorectal cancer. http://www.genexplain.com/syscol. Accessed 30 Jan 2011
TCGA (2010) The cancer genome atlas. http://cancergenome.nih.gov. Accessed 18 Oct 2010
Tomshine JC, Severson SR, Wigle DA et al (2009) Cell proliferation and epidermal growth factor signalling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem 284(39):26331–26339. Epub 2009 Jul 1
Trireme (2010) Systems-level, multi-layer understanding of cellular responses to ionizing radiation. http://www.healthcompetence.eu/converis/publicweb/project/2877;jsessionid=2e31223356d266c8188d0e9edbef. Accessed 18 Oct 2010
Tseng GC et al (2009). Investigating multi-cancer biomarkers and their cross-predictability in the expression profiles of multiple cancer types. Biomark Insights 4:57–79
Tumour-Host Genomics (2010) FP6(2010) project on tumour host genomics. http://research.med.helsinki.fi/tumorhostgenomics. Accessed 18 Oct 2010
Ullah M, Wolkenhauer O (2007) Family tree of Markov models in systems biology. IET Syst Biol 1(4):247–254
Unicellsys (2010) Eukaryotic unicellular organism biology—systems biology of the control of cell growth and proliferation. http://www.unicellsys.eu/. Accessed 18 Oct 2010
Vera J et al (2008) A systems biology approach to analyse amplification in the JAK2-STAT5 signalling pathway. BMC Syst Biol 2:38
VALAPODYN (2010) Validated predictive dynamic model of complex intracellular pathways related to the cell death and survival. http://www.valapodyn.eu/. Accessed 1 May 2010
Wang E (2010) Cancer systems biology. Chapman & Hall/CRC Mathematical & Computational Biology, Boca Raton
Weinberg RA (2007) The biology of cancer. Garland Science, New York
WTSI (2010) The wellcome trust sanger institute. http://www.sanger.ac.uk/. Accessed 18 Oct 2010
Yao T (2002) Bioinformatics for the genomic sciences and towards systems biology. Japanese activities in the post-genome era. Prog Biophys Mol Biol 80(1–2):23–42
Yuille M et al (2008) Biobanking for Europe. Briefings in bioinformatics 9(1):14–24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Marcus, F., Cesario, A. (2011). Introduction to Systems Approaches to Cancer. In: Cesario, A., Marcus, F. (eds) Cancer Systems Biology, Bioinformatics and Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1567-7_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-1567-7_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1566-0
Online ISBN: 978-94-007-1567-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)